MedTrace Logo

Digitally Delivered Exercise and Education Treatment for Low Back Pain: 3 Months Follow-up

NCT05226156 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2593

Last updated 2022-12-15

No results posted yet for this study

Summary

Exercise and education is recommended as the first-line treatment by evidence-based, international guidelines for low back pain (LBP). Despite consensus regarding treatment, there is a gap between guidelines and what is offered to patients and less than half of the patients with nonspecific low back pain receive proper first-line care.

The aim of this study was to examine the short-term effect in pain and function in people with nonspecific LBP, participating in the digitally delivered treatment program Joint Academy.

Conditions

  • Pain
  • Physical Function

Interventions

BEHAVIORAL

Digitally delivered exercise and education treatment Joint Academy

The Joint Academy® (www.jointacademy.com) program for people with LBP consists of video instructed and progressively adaptable daily exercises, patient education through text lessons and a continuous asynchronous chat function with a personal reg. physiotherapist who supervises the patient during the full participation period. The program also contains three telephone consultations with a physiotherapist that were compulsory, one at the start, one after six weeks and one after three month.

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Joint Academy

    lead INDUSTRY

Principal Investigators

  • Leif E Dahlberg, Senior professor · Arthro Therapeutics /Joint Academy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-27
Primary Completion
2022-03-15
Completion
2022-03-16

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05226156 on ClinicalTrials.gov